Fingerprint
Dive into the research topics of 'Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically